Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan, Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, Institute of Gerontology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Institute of Public Health, School of Medicine, National Yang-Ming University, Taiwan, Division of Mental Health and Addiction Medicine, Institute of Population Health Sciences, National Health Research Institutes, Taiwan, Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Taiwan, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA and Department of Genome Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Int J Epidemiol. 2013 Aug;42(4):1087-99. doi: 10.1093/ije/dyt121.
Our understanding of whether the use of acetaminophen and/or antibiotics in early life can cause allergic diseases in later childhood remains inconclusive. The objective of this study was to investigate the temporal relationship between exposure to acetaminophen and/or antibiotics in early life and the development of allergic diseases in later childhood, using two independent birth cohorts derived from the National Health Insurance Research Database (NHIRD) in Taiwan.
The authors conducted a prospective birth cohort study of 263 620 children born in 1998 and 9910 children born in 2003, separately, from the NHIRD. Exposure status of acetaminophen and/or antibiotics and potential confounding factors were included in the analyses. Cox proportional hazards models were applied to determine the temporal relationship between acetaminophen and/or antibiotic exposure and the development of allergic diseases.
We observed a positive relationship between acetaminophen and/or antibiotic exposure during the 1st year of life and the subsequent development of the three examined allergic diseases (atopic dermatitis, asthma and allergic rhinitis) in the 1998 birth cohort, but the observed relationship of drug exposure in the 2003 cohort, especially for atopic dermatitis and asthma, was lower than for those in the 1998 cohort and was not statistically significant.
Our findings provide suggestive evidence that the temporal effect of exposure to acetaminophen and/or antibiotics influences the development of common allergic diseases in later childhood. Further functional studies and/or animal studies are needed to better understand the underlying regulatory mechanisms driving this important clinical and public health issue.
我们对于在生命早期使用对乙酰氨基酚和/或抗生素是否会导致儿童后期发生过敏性疾病的理解仍存在分歧。本研究的目的是通过来自台湾全民健康保险研究数据库(NHIRD)的两个独立的出生队列,调查生命早期接触对乙酰氨基酚和/或抗生素与儿童后期过敏性疾病发展之间的时间关系。
本研究对分别来自 NHIRD 的 263620 名 1998 年出生的儿童和 9910 名 2003 年出生的儿童进行了前瞻性出生队列研究。在分析中纳入了对乙酰氨基酚和/或抗生素的暴露状况和潜在混杂因素。应用 Cox 比例风险模型来确定对乙酰氨基酚和/或抗生素暴露与过敏性疾病发展之间的时间关系。
我们观察到在生命的第 1 年接触对乙酰氨基酚和/或抗生素与 1998 年出生队列中随后发生的三种过敏性疾病(特应性皮炎、哮喘和过敏性鼻炎)之间存在正相关关系,但在 2003 年出生队列中观察到的药物暴露关系,尤其是特应性皮炎和哮喘,低于 1998 年出生队列,且无统计学意义。
我们的研究结果提供了有提示意义的证据,表明接触对乙酰氨基酚和/或抗生素的时间效应会影响儿童后期常见过敏性疾病的发展。需要进一步的功能研究和/或动物研究来更好地理解驱动这一重要临床和公共卫生问题的潜在调节机制。